Bill

Bill > A2472


NJ A2472

NJ A2472
Requires DHS to make list of drugs with "black box" warnings accessible through its website.


summary

Introduced
01/09/2024
In Committee
01/09/2024
Crossed Over
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

This bill requires the Department of Health (DOH) to post on its website a list of all drugs that are required by the federal Food and Drug Administration (FDA) to carry a "black box" warning on their label. The bill provides that if the FDA makes this information available to the public on its own website on or after the effective date of the bill, the DOH website may provide a hypertext link to that information as an alternative to posting the list of those drugs. A "black box" warning, which the FDA requires a pharmaceutical company to place on a drug label if medical studies indicate that the drug carries a significant risk of serious or life-threatening adverse effects, is the most serious warning that the FDA requires to be placed on the label of a prescription medication.

AI Summary

This bill requires the Department of Health (DOH) to post on its website a list of all drugs that are required by the federal Food and Drug Administration (FDA) to carry a "black box" warning on their label. A "black box" warning is the most serious warning that the FDA requires to be placed on the label of a prescription medication, indicating that the drug carries a significant risk of serious or life-threatening adverse effects. If the FDA makes this information available on its own website, the DOH website may provide a hyperlink to that information instead of posting the list directly.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Introduced, Referred to Assembly Aging and Human Services Committee (on 01/09/2024)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...